# RAMELTEON
> **ANDA215435** · Abbreviated New Drug Application (Generic) · Sponsor: ANDAS 5 HOLDING · Approved 2022-08-24
## Drug
- **FDA Application Number:** ANDA215435
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RAMELTEON
- **Generic name:** RAMELTEON
- **Active ingredients:** RAMELTEON
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ANDAS 5 HOLDING
- **Manufacturer:** Kanchan Healthcare Inc
- **First approval:** 2022-08-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215435)
---
*AI Analytics · CC0 1.0*